arrow
P

Patricia C. Valery

The Kids Research Institute Australia
H指数:48
被引数:8,468

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

2026-07-010
PRE
Spleen size may also be an important prognostic indicator of liver-related outcomes in metabolic-dysfunction-associated steatotic liver disease patients without clinically significant portal hypertension

脾脏大小也可能是代谢功能障碍相关脂肪性肝病无临床显著门静脉高压患者肝脏相关结局的一个重要预后指标。

2026-02-240
PRE
Clinical practice guidelines for hepatocellular carcinoma surveillance for people at high risk in Australia: summary of recommendations

澳大利亚高风险人群肝细胞癌筛查临床实践指南:推荐意见摘要

2025-09-210
OAAI
A population-based study of cause-specific mortality in First Nations Australians with cirrhosis: impact of cardiometabolic comorbidities and liver disease risk factors

一项关于澳大利亚原住民肝硬化患者病因特异性死亡率的基于人群的研究:心血管代谢合并症和肝病危险因素的影响

2025-07-220
PREAI
Alcohol does not impact chronic hepatitis C treatment outcomes but increases risk for progressive liver disease: Findings from a prospective multicentre Australian study (OPERA-C)
2024-08-020
OAAI
Broadening and strengthening the health providers caring for patients with chronic hepatitis C may improve continuity of care
2023-12-191
OAAI
Lower prevalence of elevated liver stiffness measurements in people with type 2 diabetes taking sodium-glucose co-transporter 2 inhibitors or glucagon-like peptide-1 receptor agonists

服用钠-葡萄糖共转运蛋白2抑制剂或胰高血糖素样肽1受体激动剂的2型糖尿病患者肝脏硬度升高的发生率较低

2023-11-015
OAAI